Servier and Day One Biopharmaceuticals announce acquisition to expand Servier's rare oncology portfolio

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Servier-Day-One-Pharm

More Like This

PR Newswire associated0

Servier delivers solid performance in 2024/25 and confirms its forecasts for 2030

BeOne Medicines Highlights Global Oncology Leadership at 44th Annual J.P. Morgan Healthcare Conference

PR Newswire associated0

Servier's Voranigo® (vorasidenib) Receives Prix Galien Awards Across Multiple Regions

BeOne Medicines Showcases Groundbreaking Oncology Pipeline at R&D Day

BeOne Medicines' biologics manufacturing facility and clinical R&D center in Hopewell, NJ.

BeOne Medicines Launches Following Redomiciliation to Switzerland, Marking a New Chapter in Global Oncology

PR Newswire associated0

DayOne Launches as an Independent Global Data Center Pioneer Following Series B Funding Closure

BeOne Medicines to Host Investor R&D Day Webcast on June 26, 2025

Leading Pharmaceutical Company Selects Kinaxis to Cure Supply Chain Headaches